HALO
HALOZYME THERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$122.50
+0.54%Forward multiples
Based on analyst estimates
- P/E forward
- 12.27x
- P/E 2026E
- 14.28x
- P/E 2027E
- 11.82x
- P/E 2028E
- 10.18x
- P/S forward
- 6.69x
Trailing multiples
Trailing twelve months
- P/E TTM
- 34.80x
- PEG TTM
- 0.19x
- Price / book
- 96.86x
- Price / sales
- 8.36x
- Price / cash flow
- 16.98x
Enterprise value
- Enterprise value
- $15.8B
- EV / sales
- 9.51x
- EV / EBITDA
- 22.02x
- EV / EBIT
- 17.00x
- Market cap
- $13.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026